SCHEDULE: Armistice Capital Discloses 4.99% Stake in SeaStar Medical

Sentiment:

Beneficial Ownership Report


Armistice Capital and Steven Boyd have filed an amended Schedule 13G, disclosing a 4.99% beneficial ownership stake in SeaStar Medical Holding Corp.

Summary

  • Armistice Capital, LLC and Steven Boyd reported beneficial ownership of 1,466,096 shares of SeaStar Medical Holding Corp. Common Stock.
  • This represents 4.99% of the company's outstanding common stock.
  • The filing is an Amendment No. 1 to a previous Schedule 13G.
  • The shares are held with shared voting power and shared dispositive power by both Armistice Capital, LLC and Steven Boyd.
  • The event requiring this filing occurred on June 30, 2025, with the statement filed on August 14, 2025.
  • Armistice Capital, LLC acts as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of the shares.

Sentiment

Score: 5

Explanation: This is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's performance or prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant ownership stake held by an institutional investor, which can influence market perception and liquidity.

Key Dates

DateDescription
06/30/2025Date of event requiring the filing of this statement.
08/14/2025Date the Schedule 13G Amendment No. 1 was filed.

Keywords

SeaStar Medical Holding Corp, Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.